SEC Comment Letter 0000000000-23-001065 to BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
Date: Feb. 1, 2023 · CIK: 0001580063 · Accession: 0000000000-23-001065
AI Filing Summary & Sentiment
File numbers found in text: 333-269446
Letter
United States securities and exchange commission logo February 1, 2023 Aditya Mohanty Chief Executive Officer BIORA THERAPEUTICS, INC. 4330 La Jolla Village Drive, Suite 300 San Diego, CA 92122 Re:BIORA THERAPEUTICS, INC. Registration Statement on Form S-3 Filed January 27, 2023 File No. 333-269446 Dear Aditya Mohanty: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cindy Polynice at 202-551-8707 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan Murr, Esq.
Show Raw Text
United States securities and exchange commission logo
February 1, 2023
Aditya Mohanty
Chief Executive Officer
BIORA THERAPEUTICS, INC.
4330 La Jolla Village Drive, Suite 300
San Diego, CA 92122
Re:BIORA THERAPEUTICS, INC.
Registration Statement on Form S-3
Filed January 27, 2023
File No. 333-269446
Dear Aditya Mohanty:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Cindy Polynice at 202-551-8707 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Ryan Murr, Esq.